A brand-new cardiorenal syndrome in the COVID-19  setting

Mugurel Apetrii1,2, Stefana Enache3, Dimitrie Siriopol1,2

  • 1Nephrology Clinic, Dialysis and Renal Transplant Center, "C.I. PARHON" University Hospital, Iasi, Romania.

Insights

Coronaviruses, including COVID-19, can affect the heart and kidneys, not just the lungs. The virus uses the ACE2 receptor, which is present in the heart, to cause cardiovascular issues.

Area of Science:

  • Virology
  • Cardiology
  • Infectious Diseases

Background:

  • Coronaviruses are significant pathogens causing respiratory infections in adults.
  • The COVID-19 pandemic, caused by SARS-CoV-2, primarily affects the lungs.
  • Emerging data link SARS-CoV-2 to cardiovascular complications.

Purpose of the Study:

  • To investigate the link between coronavirus infections and cardiovascular system impact.
  • To understand the role of ACE2 in SARS-CoV-2-related cardiovascular manifestations.

Main Methods:

  • Review of existing literature on coronaviruses and COVID-19.
  • Analysis of studies documenting SARS-CoV-2 interactions with ACE2.
  • Examination of reported cardiovascular and renal complications in COVID-19 patients.

Main Results:

  • Coronaviruses cause significant respiratory tract infections in adults.
  • COVID-19 has been associated with myocarditis, myocardial infarction, heart failure exacerbation, and acute kidney injury.
  • SARS-CoV-2 utilizes the ACE2 receptor for cellular entry, and ACE2 is expressed in cardiac tissue.

Conclusions:

  • Coronaviruses, particularly SARS-CoV-2, pose a threat beyond the respiratory system, affecting the cardiovascular system.
  • The expression of ACE2 in the heart provides a molecular mechanism for viral-induced cardiac pathology.
  • Further research is warranted to fully elucidate the cardiovascular sequelae of COVID-19.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
773
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
300
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
323
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
201
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
749
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
206